JAK inhibitor safety compared to traditional systemic immunosuppressive therapies

被引：0
|
作者：
Bunick, Christopher [1 ,2 ]
Daniele, Stefano [3 ]
机构：
[1] Yale Univ, Dept Dermatol, New Haven, CT USA
[2] Yale Univ, Program Translat Biomed, New Haven, CT USA
[3] Yale Sch Med, Med Scientist Training Program, New Haven, CT USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
43852
引用
收藏
页码：AB60 / AB60
页数：1
相关论文
共 50 条
  • [21] Cancer in pregnancy: safety and efficacy of systemic therapies
    Boere, Ingrid
    Lok, Christianne
    Vandenbroucke, Tineke
    Amant, Frederic
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 328 - 334
  • [22] Safety of current systemic therapies for nail psoriasis
    Hwang, Jonathan K. K.
    Lipner, Shari R. R.
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (05) : 391 - 406
  • [23] Comparative Safety of Therapies in Systemic Lupus Erythematosus
    Mosak, Joseph
    Furie, Richard
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2012, 38 (04) : 795 - +
  • [24] Immunosuppressive and immunomodulatory therapies for neuromuscular diseases. Part I: Traditional agents
    Farmakidis, Constantine
    Dimachkie, Mazen M.
    Pasnoor, Mamatha
    Barohn, Richard J.
    MUSCLE & NERVE, 2020, 61 (01) : 5 - 16
  • [25] Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies
    Passamonti, Francesco
    Maffioli, Margherita
    Caramazza, Domenica
    Cazzola, Mario
    ONCOTARGET, 2011, 2 (06) : 485 - 490
  • [26] Safety of Immunosuppressive Drugs in Pregnant Women With Systemic Inflammatory Diseases
    Kim, Seoyoung C.
    Hernandez-Diaz, Sonia
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (02) : 246 - 249
  • [27] Management of juvenile-onset systemic sclerosis with systemic immunosuppressive therapies: An evidence-based review
    Abduelmula, Abrahim
    Rankin, Brian D.
    Luca, Nadia J.
    Prajapati, Vimal H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (01) : 234 - 236
  • [28] JAK inhibitor safety information updated with risk minimisation measures
    Reactions Weekly, 2023, 1951 (1) : 2 - 2
  • [29] Review of safety and efficacy of approved systemic psoriasis therapies
    Kaushik, Shivani B.
    Lebwohl, Mark G.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (06) : 649 - 658
  • [30] Safety of systemic therapies for psoriasis on reproductive potential and outcomes
    Yiu, Z. Z. N.
    Warren, R. B.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 53 - 54
12345